Pseudomonas aeruginosa and cystic fibrosis: Correlation between exoenzyme production and patient's clinical state
Corresponding Author
P. Lanotte PharmD
Département de Microbiologie Médicale et Moléculaire, EA 3250, Faculté de Médecine, Tours, France
Département de Microbiologie Médicale et Moléculaire, Faculté de Médecine, 2 bis Bd. Tonnellé, F-37044 Tours Cedex, France.Search for more papers by this authorL. Mereghetti MD, PhD
Département de Microbiologie Médicale et Moléculaire, EA 3250, Faculté de Médecine, Tours, France
Search for more papers by this authorB. Lejeune PharmD
Laboratoire de Biophysique et Mathématiques, Faculté de Pharmacie, Tours, France
Search for more papers by this authorP. Massicot MD
Centre Hélio Marin, Saint-Trojan-Les-Bains, France
Search for more papers by this authorR. Quentin MD, PhD
Département de Microbiologie Médicale et Moléculaire, EA 3250, Faculté de Médecine, Tours, France
Search for more papers by this authorCorresponding Author
P. Lanotte PharmD
Département de Microbiologie Médicale et Moléculaire, EA 3250, Faculté de Médecine, Tours, France
Département de Microbiologie Médicale et Moléculaire, Faculté de Médecine, 2 bis Bd. Tonnellé, F-37044 Tours Cedex, France.Search for more papers by this authorL. Mereghetti MD, PhD
Département de Microbiologie Médicale et Moléculaire, EA 3250, Faculté de Médecine, Tours, France
Search for more papers by this authorB. Lejeune PharmD
Laboratoire de Biophysique et Mathématiques, Faculté de Pharmacie, Tours, France
Search for more papers by this authorP. Massicot MD
Centre Hélio Marin, Saint-Trojan-Les-Bains, France
Search for more papers by this authorR. Quentin MD, PhD
Département de Microbiologie Médicale et Moléculaire, EA 3250, Faculté de Médecine, Tours, France
Search for more papers by this authorAbstract
In this study, we investigated the correlation between the production by Pseudomonas aeruginosa isolates of four exoenzymes (protease, elastase, neuraminidase, and phospholipase C (PLC)) and the clinical state of cystic fibrosis (CF) patients. We studied 212 P. aeruginosa isolates from 22 CF patients chronically infected with this bacterium. Patients were classified into three clinical groups according to a modified Shwachman-Kulczycki-Khaw (SKK) scoring system. The production of enzymes by isolates from patients in the three populations was analyzed and compared using four statistical tests: chi-square, Mann-Whitney U, principal component analysis, and discriminant analysis. Isolates from patients with excellent or good clinical status (group I, SKK score ≥71) had higher elastase and neuraminidase activities than isolates from the other patients. In contrast, PLC activity, a common characteristic of CF isolates, was higher in isolates from patients with poor or weak clinical status (group III, SKK score ≤55). PLC also appeared to be the best parameter for differentiating between groups I and III. Enzyme production was highly variable in group II isolates (SKK score, 56–70). Our results suggest that P. aeruginosa isolates from patients with good clinical status produce large amounts of neuraminidase, and that PLC production may be involved in the decrease in pulmonary function. Pediatr Pulmonol. 2003; 36:405–412. © 2003 Wiley-Liss, Inc.
REFERENCES
- 1 Grimwood K, Semple RA, Rabin HR, Sokol PA, Woods DE. Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis. Pediatr Pulmonol 1993; 15: 135–139.
- 2 Saiman L, Ishimoto K, Lory S, Prince A. The effect of piliation and exoproduct expression on the adherence of Pseudomonas aeruginosa to respiratory epithelial monolayers. J Infect Dis 1990; 161: 541–548.
- 3 Heck LW, Alarcon PG, Kulhavy RM, Morihara K, Russell MW, Metsecky JF. Degradation of IgA proteins by Pseudomonas aeruginosa elastase. J Immunol 1990; 144: 2253–2257.
- 4 Kamath S, Kapatral V, Chakrabarty AM. Cellular function of elastase in Pseudomonas aeruginosa: role in the cleavage of nucleoside diphosphate kinase and in alginate synthesis. Mol Microbiol 1998; 30: 933–941.
- 5 Azghani AO, Bedinghaus T, Klein R. Detection of elastase from Pseudomonas aeruginosa in sputum and its potential role in epithelial cell permeability. Lung 2000; 178: 181–189.
- 6 de Bentzmann S, Polette M, Zahm JM, Hinnrasky J, Kileztky C, Bajolet O, Klossek JM, Filloux A, Lazdunski A, Puchelle E. Pseudomonas aeruginosa virulence factors delay airway epithelial wound repair by altering the actin cytoskeleton and inducing overactivation of epithelial matrix metalloproteinase-2. Lab Invest 2000; 80: 209–219.
- 7 Kon Y, Tsukada H, Hasegawa T, Igarashi K, Wada K, Suzuki E, Arakawa M, Gejyo F. The role of Pseudomonas aeruginosa elastase as a potent inflammatory factor in a rat air pouch inflammation model. FEMS Immunol Med Microbiol 1999; 25: 313–321.
- 8 Sokol PA, Kooi C, Hodges RS, Cachia P, Woods DE. Immunization with a Pseudomonas aeruginosa elastase peptide reduces severity of experimental lung infections due to P. aeruginosa or Burkholderia cepacia. J Infect Dis 2000; 181: 1682–1692.
- 9 Jaffar-Bandjee MC, Ladzunski A, Bally M, Carrère J, Chalazette JP, Galabert C. Production of elastase, exotoxin A, and alkaline protease in sputa during pulmonary exacerbation of cystic fibrosis patients chronically infected by Pseudomonas aeruginosa. J Clin Microbiol 1995; 33: 924–929.
- 10 Ostroff RM, Vasil AL, Vasil ML. Molecular comparison of a nonhemolytic and a hemolytic phospholipase C from Pseudomonas aeruginosa. J Bacteriol 1990; 172: 5915–5923.
- 11 Holm BA, Keicher L, Liu MY, Sokolowski J, Enhorning G. Inhibition of pulmonary surfactant function by phospholipases. J Appl Physiol 1991; 71: 317–321.
- 12 Lema G, Dryja D, Vargas I, Enhorning G. Pseudomonas aeruginosa from patients with cystic fibrosis affects function of pulmonary surfactant. Pediatr Res 2000; 47: 121–126.
- 13 Konig B, Vasil ML, Konig W. Role of haemolytic and non-haemolytic phospholipase C from Pseudomonas aeruginosa in interleukin-8 release from human monocytes. J Med Microbiol 1997; 46: 471–478.
- 14 Meyers DJ, Berk RS. Characterization of phospholipase C from Pseudomonas aeruginosa as a potent inflammatory agent. Infect Immun 1990; 58: 659–666.
- 15 Terada LS, Johansen KA, Nowbar S, Vasil AI, Vasil ML. Pseudomonas aeruginosa hemolytic phospholipase C suppresses neutrophil respiratory burst activity. Infect Immun 1999; 67: 2371–2376.
- 16 Cacalano G, Kays M, Saiman L, Prince A. Production of Pseudomonas aeruginosa neuraminidase is increased under hyperosmolar conditions and is regulated by genes involved in alginate expression. J Clin Invest 1992; 89: 1866–1874.
- 17 Imundo L, Barasch J, Prince A, Al-Awqati Q. Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. Proc Natl Acad Sci USA 1995; 92: 3019–3023.
- 18 de Bentzmann S, Roger P, Dupuit F, Bajolet-Laudinat O, Fuchey C, Plotkowski MC, Puchelle E. Asialo GM1 is a receptor for Pseudomonas aeruginosa adherence to regenerating respiratory epithelial cells. Infect Immun 1996; 64: 1582–1588.
- 19 Saiman L, Prince A. Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. J Clin Invest 1993; 92: 1875–1880.
- 20 Saiman L, Cacalano G, Gruenert D, Prince A. Comparison of adherence of Pseudomonas aeruginosa to respiratory epithelial cells from cystic fibrosis patients and healthy subjects. Infect Immun 1992; 60: 2808–2814.
- 21 Martin C, Boyd EF, Quentin R, Massicot P, Selander RK. Enzyme polymorphism in Pseudomonas aeruginosa strains recovered from cystic fibrosis patients in France. Microbiology 1999; 145: 2587–2594.
- 22 Doershuck CF, Matthews LW, Tucker AS, Spector S. Evaluation of a prophylactic and therapeutic program for patients with cystic fibrosis. Pediatrics 1965; 36: 675–688.
- 23 Shwachman H, Kulczycki LL, Khaw KT. Studies in cystic fibrosis: a report on sixty-five patients over 17 years of age. Pediatrics 1965; 36: 689–699.
- 24 Woods DE, Schaffer MS, Rabin HR, Campbell GD, Sokol PA. Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites. J Clin Microbiol 1986; 24: 260–264.
- 25 Bjorn MJ, Sokol PA, Iglewski BH. Influence of iron on yields of extracellular products in Pseudomonas aeruginosa. J Bacteriol 1979; 138: 193–200.
- 26 Berka RM, Gray GL, Vasil ML. Studies of phospholipase C (heat-labile) hemolysin in Pseudomonas aeruginosa. Infect Immun 1981; 34: 1071–1074.
- 27 Warren L. The thiobarbituric acid assay of sialic acids. J Biol Chem 1959; 234: 1971–1975.
- 28 Anderson TW. An introduction to multivariate statistical analysis. 2nd ed. New York: Wiley; 1984.
- 29 Hand DJ. Discrimination and classification. Chichester: Wiley; 1981.
- 30 Whiteley M, Bangera MG, Bumgarner RE, Parsek MR, Teitzel GM, Lory S, Greenberg EP. Gene expression in Pseudomonas aeruginosa biofilm. Nature 2001; 413: 860–864.
- 31 Friedrichs F, Kusenbach G, Skopnik H, Benz-Bohm G, Dohmen H, Heimann G. Cardiopulmonary capacity in patients with mucoviscidosis. Comparison of ergospirometry findings with clinical and radiological scores. Monatsschr Kinderheilkd 1992; 140: 864–868.
- 32 Davies J, Dewar A, Bush A, Pitt T, Gruenert D, Geddes DM, Alton EW. Reduction in the adherence of Pseudomonas aeruginosa to native cystic fibrosis epithelium with anti-asialoGM1 antibody and neuraminidase inhibition. Eur Respir J 1999; 13: 565–570.
- 33 Scharfman A, Ramphal R, Neut C, Carnoy C, Lamblin G, Roussel P. Arylneuraminidase activity of Pseudomonas aeruginosa does not degrade natural substrates such as human respiratory mucins. Infect Immun 1991; 59: 4283–4285.
- 34 Songer JG. Bacterial phospholipases and their role in virulence. Trends Microbiol 1997; 5: 156–161.
Citing Literature
